A 5-yr retrospective study in livestock slaughtered in abattoirs was carried out in Khuzestan Province (southwestern Iran) to determine the prevalence of parasitic infections responsible for condemnation of slaughtered animals' carcasses and viscera. The economic importance of such infections in terms of lost meat and offal were also estimated. Between 20 March 2006 and 19 March 2011, 125,593 cattle, 1,191,871 sheep, 240,221 goats, and 25,010 buffalos were slaughtered in the study area; the livers of 58,753 (3.7%; 95% confidence interval [CI]: 3.7-3.8%), the lungs of 34,522 (2.2%; 95% CI: 2.1-2.2%), and the carcasses of 78 (0.0049% 95% CI: 0.0048-0.0049%) of these animals were condemned. Proportions of liver, lung, and carcass condemnations during the 5-yr study period in buffalos were significantly greater than the other species (P < 0.001). Frequency of liver condemnation during the 5-yr period for cattle was greater than sheep and goats (P < 0.001), but condemnation of lungs in goat was significantly greater than sheep and cattle (P < 0.001). The parasitic lesions observed in the condemned livers were attributed to Echinococcus granulosus, Fasciola hepatica, or Dicrocoelium dendriticum, or some combination of these species. All the parasitic lesions observed in the condemned lungs from cattle, sheep, goats, and buffalos are ascribed to E. granulosus. Sarcocystis spp. cysts were found in ovine and buffalo muscles, whereas Taenia sp. cysticerci were detected in bovine muscle. Muscles of goats were devoid of any parasitic lesions. Parasites were responsible for 54.1% of the condemned organs or carcasses, with a retail value (based on market prices in 2011) of $1,148,181 (U.S.) ($137,880 for cattle, $602,699 for sheep, $280,955 for goats, and $126,647 for buffalos). The parasites contributing most to the condemnation of otherwise marketable organs and flesh were E. granulosus (29.2%) and F. hepatica (18.6%). These parasites clearly remain the most common, causing considerable economic loss in Khuzestan Province and, presumably, other areas of Iran.

In nine districts in the north of Khorasan province, in north-eastern Iran, a 5-year retrospective study was carried out to determine the prevalences, in livestock slaughtered in abattoirs, of the parasitic infections responsible for the condemnation of the animals' carcasses and viscera (and the economic importance of such infections in terms of lost meat and offal). Between 20 March 2005 and 19 March 2010, 436,620 animals (45,360 cattle, 275,439 sheep, 115,674 goats and 147 camels) were slaughtered in the study area and the livers of 30,207 (6.9%), the lungs of 23,259 (5.3%) and the carcasses of 1072 (0.2%) of these animals were condemned. Almost all (92.4%) of the condemned livers, most (68.9%) of the condemned lungs but only 10.8% of the condemned carcasses were rejected because of parasitic infection. The parasitic lesions observed in the condemned livers were attributed to Echinococcus granulosus, Fasciola hepatica and/or Dicrocoelium dendriticum (cattle, sheep and goats) or entirely to E. granulosus (camels). All the parasitic lesions observed in the condemned lungs (which also came from cattle, sheep, goats and camels) were attributed to E. granulosus. Sarcocystis cysts and/or Taenia cysticerci were found in ovine muscle while only Taenia cysticerci were detected in bovine muscle (no parasitic lesions were observed in the muscles of the goats and camels). Parasites were responsible for 80.8% of the condemned organs or carcasses, and the value of the food lost because of parasite-related condemnation (based on market prices in 2010) was estimated to be U.S.$421,826 (U.S.$47,980 for cattle, U.S.$316,344.0 for sheep, U.S.$57,372 for goats and U.S.$130 for camels). The parasites contributing most to the condemnation of otherwise marketable organs and muscles were E. granulosus (52.2%) and D. dendriticum flukes (29.5%). These parasites clearly remain too common and cause considerable economic loss in Khorasan and, presumably, other areas of Iran.

Hydatid cysts have been widely recognized for decades as a common medical problem that affects millions of people. A revolution in medical treatment may be on the prospect of nanotechnology enhancing chemotherapy against hydatid cysts. An overview of nanotechnology’s impact on chemotherapeutics is presented in the current review. It discusses some of the challenges as well as some of the opportunities. The application of nanotechnology to enhance chemotherapy against hydatid cysts is what this review will explore. Nanotechnology is a critical component of delivering therapeutic agents with greater precision and efficiency and targeting hydatid cysts with better efficacy, and minimizing interference with surrounding tissue. However, there are biodistribution challenges, toxicity, and resistance problems associated with nanotherapeutics. Additionally, nanobiosensors are being investigated to enable the early diagnosis of hydatid cysts. A nanobiosensor can detect hydatid cysts by catching them early, non-invasively, rapidly, and accurately. The sensitivity and specificity of diagnostic tests can be enhanced with nanobiosensors because they take advantage of the unique properties of nanomaterials. By providing more precise and customized treatment options for hydatid cysts, nanotechnology may improve therapeutic options and strategies for diagnosing the disease. In conclusion, treatment with nanotechnology to treat hydatid cysts is potentially effective but presents many obstacles. Furthermore, nanobiosensors are being integrated into diagnostic techniques, as well as helping to diagnose patients earlier and more accurately.